Table 1:
Absolute Contraindications |
Early phase after acute coronary syndrome (within 2 days) |
Ongoing unstable angina |
Uncompensated heart failure |
Acute thrombophlebitis or recent embolism (pulmonary or systemic) |
Active endocarditis Acute myocarditis or pericarditis |
Acute aortic dissection |
Symptomatic severe aortic stenosis |
Acute systemic illness or fever |
Uncontrolled hypertension (≥180 mmHg systolic or ≥110mmHg diastolic blood pressure at rest) |
Uncontrolled sinus tachycardiac (resting heart rate >120 beats.min–1) |
Uncontrolled or life-threatening atrial or ventricular dysrhythmias (including new onset atrial fibrillation/flutter) |
Third-degree atrioventricular block without pacemaker |
Uncontrolled diabetes mellitus |
Orthostatic drop in blood pressure (>20mmHg) with symptoms |
Progressive worsening of exercise tolerance or dyspnea at rest or on exertion over previous 3–5 days |
Significant ischemia at low work rates (<2 METs or 50 Watts) |
Relative Contraindications (increased risk) |
≥1.8 kg or 3 lbs increase in body mass over previous 1–3 days |
Concurrent continuous or intermittent dobutamine therapy |
Decrease in systolic blood pressure with exercise |
New York Heart Association Functional Class IV |
Complex ventricular arrhythmias at rest or appearing with exertion |
Supine resting heart rate ≥100 beats.min–1 |
Pre-existing co-morbidities limiting exercise tolerance |
Severe hypertrophic obstructive cardiomyopathy |
Symptoms or indications of worsening heart failure |
≥1.8 kg or 3 lbs increase in body mass over previous 1–3 days |
Worsening dyspnea (on exertion or rest) |
Excessive fatigue, lack of energy |
Swelling of legs, abdomen |
Productive cough |
Increased urination, particularly at night (nocturia) |
Difficulty sleeping due to breathing problems (orthopnea) |
Difficulty concentrating |
Shock from an implantable cardiac defibrillator |